761 related articles for article (PubMed ID: 19040281)
1. Molecular characterization of a variant virus that caused de novo hepatitis B without elevation of hepatitis B surface antigen after chemotherapy with rituximab.
Miyagawa M; Minami M; Fujii K; Sendo R; Mori K; Shimizu D; Nakajima T; Yasui K; Itoh Y; Taniwaki M; Okanoue T; Yoshikawa T
J Med Virol; 2008 Dec; 80(12):2069-78. PubMed ID: 19040281
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
Yeo W; Chan TC; Leung NW; Lam WY; Mo FK; Chu MT; Chan HL; Hui EP; Lei KI; Mok TS; Chan PK
J Clin Oncol; 2009 Feb; 27(4):605-11. PubMed ID: 19075267
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role.
Steinberg JL; Yeo W; Zhong S; Chan JY; Tam JS; Chan PK; Leung NW; Johnson PJ
J Med Virol; 2000 Mar; 60(3):249-55. PubMed ID: 10630955
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
Alexopoulou A; Theodorou M; Dourakis SP; Karayiannis P; Sagkana E; Papanikolopoulos K; Archimandritis AJ
J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845
[TBL] [Abstract][Full Text] [Related]
5. Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer.
Borentain P; Colson P; Coso D; Bories E; Charbonnier A; Stoppa AM; Auran T; Loundou A; Motte A; Ressiot E; Norguet E; Chabannon C; Bouabdallah R; Tamalet C; Gérolami R
J Viral Hepat; 2010 Nov; 17(11):807-15. PubMed ID: 20002298
[TBL] [Abstract][Full Text] [Related]
6. Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma.
Matsue K; Kimura S; Takanashi Y; Iwama K; Fujiwara H; Yamakura M; Takeuchi M
Cancer; 2010 Oct; 116(20):4769-76. PubMed ID: 20597091
[TBL] [Abstract][Full Text] [Related]
7. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela.
Gutiérrez C; Devesa M; Loureiro CL; León G; Liprandi F; Pujol FH
J Med Virol; 2004 Jun; 73(2):200-7. PubMed ID: 15122793
[TBL] [Abstract][Full Text] [Related]
8. Reactivation of hepatitis B virus infection with persistently negative HBsAg on three HBsAg assays in a lymphoma patient undergoing chemotherapy.
Cheung WI; Chan HL; Leung VK; Tse CH; Fung K; Lin SY; Wong A; Wong VW; Chau TN
J Clin Virol; 2010 Feb; 47(2):193-5. PubMed ID: 20031483
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic hepatitis B virus (HBV) reactivation despite reduced viral fitness is associated with HBV test and immune escape mutations in an HIV-coinfected patient.
Henke-Gendo C; Amini-Bavil-Olyaee S; Challapalli D; Trautwein C; Deppe H; Schulz TF; Heim A; Tacke F
J Infect Dis; 2008 Dec; 198(11):1620-4. PubMed ID: 18847320
[TBL] [Abstract][Full Text] [Related]
10. A novel hepatitis B virus variant S 129 (Gln-->Leu): lack of correlation between antigenicity and immunogenicity.
Wu L; He JW; Yao X; Li HM; Wen YM
J Med Virol; 1999 Dec; 59(4):424-30. PubMed ID: 10534722
[TBL] [Abstract][Full Text] [Related]
11. Role of surface promoter mutations in hepatitis B surface antigen production and secretion in occult hepatitis B virus infection.
Sengupta S; Rehman S; Durgapal H; Acharya SK; Panda SK
J Med Virol; 2007 Mar; 79(3):220-8. PubMed ID: 17245717
[TBL] [Abstract][Full Text] [Related]
12. [Prevention of hepatitis B virus reactivation in B-cell lymphoma patients receiving chemotherapy with rituximab].
Mimura N; Kojima H; Tsujimura H; Ise M; Sakai C; Fukai K; Yokosuka O; Kumagai K
Rinsho Ketsueki; 2010 Mar; 51(3):213-5. PubMed ID: 20379117
[TBL] [Abstract][Full Text] [Related]
13. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
Ji D; Cao J; Hong X; Li J; Wang J; Chen F; Wang C; Zou S
Eur J Haematol; 2010 Sep; 85(3):243-50. PubMed ID: 20491883
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of HBV genomes from patients with fulminant hepatitis.
Sterneck M; Kalinina T; Günther S; Fischer L; Santantonio T; Greten H; Will H
Hepatology; 1998 Nov; 28(5):1390-7. PubMed ID: 9794926
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization and functional analysis of occult hepatitis B virus infection in Chinese patients infected with genotype C.
Fang Y; Teng X; Xu WZ; Li D; Zhao HW; Fu LJ; Zhang FM; Gu HX
J Med Virol; 2009 May; 81(5):826-35. PubMed ID: 19319940
[TBL] [Abstract][Full Text] [Related]
16. [An in vitro model of hepatitis B virus gene replication and expression in primary rat hepatocytes transfected with circular viral DNA].
Yao YQ; Zhang DF; Luo Y; Zhang DZ; Huang AL; Wang B; Zhou WP; Ren H; Guo SH
Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):275-8. PubMed ID: 12223138
[TBL] [Abstract][Full Text] [Related]
17. Prospective analysis of hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma after rituximab combination chemotherapy.
Niitsu N; Hagiwara Y; Tanae K; Kohri M; Takahashi N
J Clin Oncol; 2010 Dec; 28(34):5097-100. PubMed ID: 20837949
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study.
Yeo W; Chan PK; Hui P; Ho WM; Lam KC; Kwan WH; Zhong S; Johnson PJ
J Med Virol; 2003 Aug; 70(4):553-61. PubMed ID: 12794717
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection.
Kumar GT; Kazim SN; Kumar M; Hissar S; Chauhan R; Basir SF; Sarin SK
J Gastroenterol Hepatol; 2009 Apr; 24(4):588-98. PubMed ID: 19207682
[TBL] [Abstract][Full Text] [Related]
20. Virological and clinical characteristics on reactivation of occult hepatitis B in patients with hematological malignancy.
Sugauchi F; Tanaka Y; Kusumoto S; Matsuura K; Sugiyama M; Kurbanov F; Ueda R; Mizokami M
J Med Virol; 2011 Mar; 83(3):412-8. PubMed ID: 21264861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
